Optimizing vaccine design for Alzheimer’s disease TORONTO, Ontario and CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced… Read More..

BEIJING, March 7, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that the company established a new subsidiary in Hainan island to expand the capacity of nutrition enhanced corn production. The new wholly owned subsidiary in Hainan province will focus… Read More..

ATLANTA, March 08, 2022--(BUSINESS WIRE)--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases, including fibromyalgia, announced today that Greg Duncan, Chairman and Chief Executive Officer, will participate in a fireside chat at the 34th Annual Roth Conference on Monday, March… Read More..